Cardiac dysfunction in type II diabetes: a bittersweet, weighty problem, or both?

Area of Science:

• Cardiology
• Metabolic Disorders
• Diabetes Research

Background:

• Obesity and type 2 diabetes are linked to impaired left ventricular (LV) function.
• Weight loss is known to improve LV function, but the independent and combined effects of weight loss and glycemic control on LV function in type 2 diabetes remain unclear.

Purpose of the Study:

• To investigate the incremental impact of weight loss and improved glycemic control on left ventricular (LV) function in patients with type 2 diabetes.
• To determine if benefits on LV function are mediated by weight loss or glycemic control improvements.

Main Methods:

• A 12-month case-control study involving three groups of type 2 diabetes patients with suboptimal glycemic control.
• Group 1: No improvement in HbA1c or weight loss. Group 2: Improved HbA1c (≥1%) but no weight loss. Group 3: Improved HbA1c (≥1%) and weight loss.
• Transthoracic echocardiograms were performed at baseline and follow-up to assess LV function, including global longitudinal strain (GLS).

Main Results:

• At baseline, Group 3 had the highest BMI and worst LV systolic function (GLS).
• After 12 months, both Group 2 and Group 3 showed improvements in LV ejection fraction and diastolic function, with reduced filling pressures.
• Group 3 exhibited more significant improvements in GLS compared to Group 2, with both groups achieving comparable GLS at follow-up.

Conclusions:

• In overweight patients with type 2 diabetes, weight loss and improved glycemic control have additive beneficial effects on LV systolic and diastolic function.
• These findings suggest a combined strategy of weight management and glycemic control is optimal for cardiovascular health in this population.